Pierre Étienne is a psychiatrist in the geriatric psychiatry program of the Douglas Institute. He is interested in the early development of medication and in Alzheimer's Disease.

Eduardo Chachamovich’s work focuses mainly on social and clinical determinants of mental health in Aboriginal populations.

Marcelo Berlim is mainly interested in the study and treatment of depressive disorders with the use of state-of-the-art neuromodulation techniques.

Fabrice Jollant's research focuses on the cognitive and cerebral bases of vulnerability to suicide.

John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.

Rob Whitley examines barriers and facilitators to recovery within both health services and the wider socio-cultural environment.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

Cecilia Flores' work focuses on the dysfunction of the dopaminergic system, a brain system important in reward, motor, and cognitive functions.

Joseph Rochford examines how antidepressants change behavioral and biological mechanisms involved in coping with stress.

Norbert Schmitz is involved in biostatistics, psychiatric epidemiology and psychometrics.